2019 San Antonio Breast Cancer Symposium Review

January 24, 2020

Join us in January as we review the most important findings from the 2019 San Antonio Breast Cancer Symposium. You can keep up with all the advances in diagnosis and treatment of breast cancer  — in just one day, right here in Pittsburgh.

See the symposium highlights and discuss them with our own expert faculty. Find out about new discoveries that can affect your clinical decisions about therapy for your patients.

Target Audience

This conference has been designed to provide practicing oncologists, surgeons, radiologists, and other health care professionals information on current concepts in the management of patients with breast cancer.

Learning Objectives

At the conclusion of this course, participants should be able to:

• Summarize current information relevant to the evolving biology of breast cancer related to hormonal and chemotherapy research in the adjuvant and metastatic locally advanced breast cancer setting with regard to clinical trials and treatment

• State the advances in biological prognostic factors for early stage breast cancer

• Discuss surgical management and breast conservation therapy for patients with breast cancer

Additional Information

AttachmentSize
PDF icon Diane Buchbarker, MD - SABC 2019 GS 3-02 Path complete response with or without atezolizumab.pdf971.58 KB
PDF icon Diane Buchbarker, MD - SABC 2019 GS 3-01 Keynote 522.pdf646.82 KB
PDF icon Diane Buchbarker, MD - SABC 2019 GS 1-08 Adjuvant capecitabine in combincation with docetaxel and cyclo plus epirubicin.pdf695.22 KB
PDF icon Donna Kinzler, DNP - Updates in the Management of Brain Metastases.pdf929.89 KB
PDF icon Kelly Gaertner, PharmD - Oral Paclitaxel SABCS Review.pdf1005.43 KB
PDF icon Helen Analo, MD - Updates in Adjuvant Her2 Positive Breast Cancer .pdf1.01 MB
PDF icon Helen Analo, MD - Interim Overall Survival Analysis of APHINITY.pdf853.61 KB
PDF icon Christie Hilton, DO - Updates in Metastatic Her2 Positive Breast Carcinoma .pdf1.69 MB
PDF icon Jane Raymond, MD - Advances in Management of Early Stage ER+ Breast Cancer.pdf2.4 MB
PDF icon Larisa Greenberg, MD - Role of CDK46 inhibitors in.pdf1.7 MB
PDF icon Mark Trombetta, MD - Radiation Oncology Advances .pdf303.88 KB
PDF icon Thomas Julian, MD - Surgical Considerations After Neoadjuvant Treatment.pdf364.88 KB
PDF icon Katherine Miller, MD - Breast Cancer Clinical Trials Update.pdf1 MB
Course summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Attendance
Course opens: 
10/11/2019
Course expires: 
12/31/2020
Event starts: 
01/24/2020 - 7:00am EST
Event ends: 
01/24/2020 - 4:00pm EST
Cost:
$90.00
Add to calendar: 
Rating: 
0
Pittsburgh Marriott City Center
112 Washington Pl
Pittsburgh 15219
United States

Accreditation

Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

Allegheny General Hospital designates this live activity for a maximum of 4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.

Allegheny General Hospital has approved this activity for 4.5 contact hours for non-physicians

Available Credit

  • 4.50 AMA PRA Category 1 Credit™
  • 4.50 Attendance

Price

Cost:
$90.00
Please login or register to take this course.